# Effects of Cisatracurium on Succinylcholine-induced Fasciculations and Myalgia

> **NCT02481193** · PHASE3 · COMPLETED · sponsor: **Yangzhou No.1 People's Hospital** · enrollment: 90 (actual)

## Conditions studied

- Fasciculation

## Interventions

- **DRUG:** Cisatracurium

## Key facts

- **NCT ID:** NCT02481193
- **Lead sponsor:** Yangzhou No.1 People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2015-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02481193

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02481193, "Effects of Cisatracurium on Succinylcholine-induced Fasciculations and Myalgia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02481193. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*